The market offers significant opportunities driven by increasing demand for personalized therapies, especially in oncology and rare diseases. Targete ...

Real world data that harnesses deidentified health records is a multi-billion-dollar industry. But what is the value of a ...

Here are the Kroger stores that are expected to close in August 2025, along with other expected closures coming in September and October.

More than two dozen At Home stores are set to close by the end of September as the company continues to deal with dwindling ...

The FDA issued a complete response letter to the odronextamab application in follicular lymphoma, rejecting the drug for a second time in this patient population.

Following the sale of the direct-to-consumer genetic testing company 23andMe, the Utah Attorney General’s Office is issuing a consumer advisory reminding former customers of ways to protect ...

In a major move, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is acquiring most of 23andMe’s assets for $256 million, including its personal genome service, research services, biobank, and ...

23andMe’s privacy ombudsman secured court approval to retain WilmerHale in the DNA testing company’s Chapter 11 case despite an objection from the Justice Department’s bankruptcy watchdog over ...

A new genetic test, based on data from more than five million people, can identify people at risk of severe obesity. The test can be performed on children before their genetic risk starts to shape ...

In May, Regeneron Pharmaceuticals announced it would purchase most of 23andMe's assets for $256 million after it came out on top during the bankruptcy auction.